News Contact Us

Top three trends fostering North America intragastric balloon market growth

Author : Ronak Bora | Published Date : 2021-01-05 

With minimally invasive endoscopic procedures trending across North America, the alarming prevalence of obesity and related multiple health consequences have been compelling a majority of the population to seek appropriate diagnosis, treatments, and surgeries to ensure a better quality of life in the wake of the COVID-19 pandemic.

Modern medical equipment such as the Bio-Enterics intragastric balloons (BIB) are gaining widespread popularity due to their proven records in reducing cardiovascular risks. To that end, the North America intragastric balloon industry share was estimated to be worth more than $10 million during 2019. Growing at an exponential pace between 2020 and 2026, the North America intragastric balloon market size is expected to rise at a staggering 17% CAGR, garnering over $35 million by 2026.

Request a sample of this research report @ 


The three trends that have been stimulating the North America intragastric balloon market outlook have been discussed below:

Saline-filled balloon segment to advance rapidly

The placement of saline-filled intragastric balloons has emerged as a reversible and temporary therapeutic alternative for patients with morbid obesity. The segment is projected to surge at a 16.5% CAGR through the forecast period, thanks to the growing adoption of these solutions by pre-obese and obese individuals. With benefits such as no hospital stay, lower costs, and instant results, saline-filled balloons are picking pace, thereby triggering the North America intragastric balloon market growth.

Although in April 2020, the Food and Drug Administration (FDA) recommended healthcare providers to closely monitor patients and create an awareness regarding symptoms of potential complications arising due to intragastric balloons, it declared that the surgery continues to be an appropriate treatment for obesity.

Hospitals segment to spur revenue growth

Due to improvements in metabolic parameters and weight loss, hospitals have been promoting the use of intragastric balloons. The hospitals segment is likely to surface as an important contributor in the North America intragastric balloon market outlook owing to the heavy investments in endoscopic medical devices, support from regulatory bodies including the FDA, and the availability of skilled healthcare professionals. The segment claimed a share of $4.5 million during 2019.

The increasing number of patients suffering from metabolic disorders has been encouraging the adoption of intragastric balloon surgeries amongst healthcare practitioners and patients alike. Since the COVID-19 pandemic has been responsible for increased awareness regarding weight loss and the prevention and management of obesity, the North America intragastric balloon market share is likely to increase over the upcoming period.

Make an inquiry for purchasing this report @


US to grow remarkably due to high frequency of endoscopy procedures

The number of endoscopic procedures of the lower gastrointestinal tract has been more than 20 million each year across the United States. As more patients are opting for endoscopy, the North America intragastric balloon market share is anticipated to rise substantially. The high rate of growth in therapeutic treatments and enhanced techniques for early detection of cancer have been enabling endoscopic procedures in a cost-effective and minimally invasive manner, ensuring faster recovery rates.

As opposed to traditional treatments for obesity that involve strenuous physical activity, pharmacotherapy, and lifestyle changes, implantation of intragastric balloons is convenient, simple, and effective. Consequently, Americans have been embracing safe and effective procedures such as intragastric balloon surgeries. The growing incidence of obesity, diabetes, heart diseases, and hypertension has also been pushing the North America intragastric balloon industry share.

The relatively poor outcomes of the conventional treatment alternatives have been motivating patients to achieve long-lasting weight reduction within a short time period, fostering the North America intragastric balloon industry size.

About Author

Ronak Bora

Ronak Bora

A graduate in Electronics Engineering, Ronak writes for fractovia and carries a rich experience in digital marketing, exploring how the online world works from a technical and marketing perspective. His other areas of interest include reading, music, and sport. [email protected] | https://twitter.com/RonakBora26

Related News

North America intelligent vending machine market to Dominate Worldwide by 2026

Published Date: 2021-01-16         Author: Ronak Bora

With leading enterprises including Walmart, Nespresso, CVS, and their ilk piloting intelligent vending machines at multiple and diverse venues, the North American customers have been reaping the benefits of this smart technology. Backed by the rapid approval for coffee vending machines and tea vendi... Read More

North America healthcare information technology market to gain traction by 2024

Published Date: 2021-01-16         Author: Ronak Bora

Although the chaos resulting from the COVID-19 pandemic has been a bolt from the blue, the healthcare information technology (IT) market has been making the most of the opportunities arising from the adversity. The market for healthcare IT in North America is a fertile ground for significant growth,... Read More

North America healthcare 3D printing market to record surpass USD 850 million by 2024

Published Date: 2021-01-16         Author: Ronak Bora

Considered as one of the most modern niche verticals of medical device manufacturing sector, the North America healthcare 3D printing market has gained significant prominence in recent years with the advent of innovative technologies. The transformational shift from conventional manufacturing proces... Read More

© 2021 Fractovia. All Rights Reserved